Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:04 PM
Ignite Modification Date:
2025-12-24 @ 1:04 PM
NCT ID:
NCT04900961
Eligibility Criteria:
Patients will be classified according by clinical presentation:
A) Non-hospitalised - Positive diagnosis with persisting symptoms for at least 4 weeks from symptoms onset leading to medical review (A\&E, Community COVID Hub) but not admission (Treatment group), B) Hospitalised, positive diagnosis, and with post-discharge, persistent symptoms for at least 4 weeks from symptoms onset (Treatment group), C) Hospitalised, positive diagnosis, and in convalescent phase in-hospital (Prevention group).
Groups A \& B = target population for treatment of persisting symptoms post-COVID i.e. Long-COVID; Group C = Target population for prevention of Long COVID.
Inclusion Criteria:
1. Virology PCR positive laboratory diagnosis and/or point of care test positive for COVID-and/or
2. Positive Lateral Flow Test (confirmation from notes or by participant) and/or
3. Positive COVID antibody test
4. Persistent symptoms for at least 4 weeks from symptoms onset (Groups A \& B only)
5. Presentation type - one of group A, B or C.
Exclusion Criteria:
1. Physiotherapy as part of standard care e.g. post intensive care unit (ICU), post high dependency unit (HDU),
2. No expectation of being able to walk within 3 months
3. Unable to provide informed consent,
4. Unable to comply with the protocol.
5. Known pregnancy
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT04900961
Study Brief:
Protocol Section:
NCT04900961